Ukai, M.; Yokoi, A.; Yoshida, K.; Suzuki, S.; Shibata, K.; Kikkawa, F.; Nakatsura, T.; Kajiyama, H.
Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma. Cancers 2021, 13, 550.
https://doi.org/10.3390/cancers13030550
AMA Style
Ukai M, Yokoi A, Yoshida K, Suzuki S, Shibata K, Kikkawa F, Nakatsura T, Kajiyama H.
Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma. Cancers. 2021; 13(3):550.
https://doi.org/10.3390/cancers13030550
Chicago/Turabian Style
Ukai, Mayu, Akira Yokoi, Kosuke Yoshida, Shiro Suzuki, Kiyosumi Shibata, Fumitaka Kikkawa, Tetsuya Nakatsura, and Hiroaki Kajiyama.
2021. "Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma" Cancers 13, no. 3: 550.
https://doi.org/10.3390/cancers13030550
APA Style
Ukai, M., Yokoi, A., Yoshida, K., Suzuki, S., Shibata, K., Kikkawa, F., Nakatsura, T., & Kajiyama, H.
(2021). Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma. Cancers, 13(3), 550.
https://doi.org/10.3390/cancers13030550